Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn C Buse

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
Headache|May 6, 2024
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I studyDawn C Buse, Fumihiko Sakai, Manjit Matharu, et al.
Headache|June 13, 2017
Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
Headache|February 11, 2017
Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) ScaleRichard B Lipton, Dawn C Buse, Aubrey Manack Adams, et al.
Current Medical Research and Opinion|August 20, 2019
Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims databaseJanet H Ford, Krista Schroeder, Dawn C Buse, et al.
Headache|January 25, 2012
Opioid use and dependence among persons with migraine: results of the AMPP studyDawn C Buse, Starr H Pearlman, Michael L Reed, et al.
BMC Neurology|July 4, 2024
Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card surveyDawn C Buse, Roger Cady, Amaal J Starling, et al.
Headache|December 30, 2025
Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trialNathaniel M Schuster, Mark S Wallace, Thomas D Marcotte, et al.
Clinical Therapeutics|February 8, 2022
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2Vincent Martin, A Jim Nagy, Marina Janelidze, et al.
Headache|October 17, 2017
AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical TrialRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.
The Journal of Headache and Pain|February 26, 2024
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J Starling, Roger Cady, Dawn C Buse, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
Headache|May 6, 2024
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I studyDawn C Buse, Fumihiko Sakai, Manjit Matharu, et al.
Headache|June 13, 2017
Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention StudyRichard B Lipton, Sagar Munjal, Dawn C Buse, et al.
Headache|February 11, 2017
Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) ScaleRichard B Lipton, Dawn C Buse, Aubrey Manack Adams, et al.
Current Medical Research and Opinion|August 20, 2019
Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims databaseJanet H Ford, Krista Schroeder, Dawn C Buse, et al.
Headache|January 25, 2012
Opioid use and dependence among persons with migraine: results of the AMPP studyDawn C Buse, Starr H Pearlman, Michael L Reed, et al.
BMC Neurology|July 4, 2024
Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card surveyDawn C Buse, Roger Cady, Amaal J Starling, et al.
Headache|December 30, 2025
Vaporized cannabis versus placebo for acute migraine: A randomized, double-blind, placebo-controlled crossover trialNathaniel M Schuster, Mark S Wallace, Thomas D Marcotte, et al.
Clinical Therapeutics|February 8, 2022
Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2Vincent Martin, A Jim Nagy, Marina Janelidze, et al.
Headache|October 17, 2017
AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical TrialRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.
The Journal of Headache and Pain|February 26, 2024
Harris Poll Migraine Report Card: population-based examination of high-frequency headache/migraine and acute medication overuseAmaal J Starling, Roger Cady, Dawn C Buse, et al.
Pageof 23